FIND

researchers

DISCOVER

relevant articles

PROMOTE

your research

now for free

Charles Davis

Research Profile

Disorders

Living Beings

HIV-1

Chemicals & Drugs

Procedures

Concepts & Ideas

Anatomy

Physiology

Co-author Network

Publications

TOP 3
Hana M El Sahly; Sarah L George; Christine Johnston; Karen L Kotloff; Corinne Lehmann; Jeffery Meier; Abbie Stokes-Riner; Anna Wald; Patricia L Winokur; Rebecca C Brady; Charles Davis; Wendy A Keitel
Higher antigen content improves the immune response to 2009 H1N1 influenza vaccine in HIV-infected adults: a randomized clinical trial.
Peter G Stock; Burc Barin; Barbara Murphy; Douglas W Hanto; Jorge Diego; Jimmy Light; Charles Davis; Emily A Blumberg; David Simon; ARUNA SUBRAMANIAN; J Michael Millis; G Marshall Lyon; Kenneth Brayman; Doug Slakey; Ron Shapiro; J Keith Melancon; Jeffrey M Jacobson; Valentina Stosor; Jean L Olson; Donald M Stablein; Michelle E Roland
Outcomes of kidney transplantation in HIV-infected recipients.
Cristiana Cairo; Cheryl L Armstrong; Jean-Saville Cummings; Carl O Deetz; Ming Tan; Changwan Lu; Charles Davis; C. David Pauza
Impact of age, gender, and race on circulating γδ T cells.

Register for free to view:

Visualized networks:

See your personal network in
sophisticated graphical views

GeoTargeted Searches:

Locate experts around the world
and connect with global collaborators

Research Profiles:

See the research activity
of experts around the globe

Geonetwork of Charles Davis (preview)

Cities where this author has publications
Cities where co-authors of this author have publications

Flash Player Required

All Publications

2012: Hana M El Sahly; Sarah L George; Christine Johnston; Karen L Kotloff; Corinne Lehmann; Jeffery Meier; Abbie Stokes-Riner; Anna Wald; Patricia L Winokur; Rebecca C Brady; Charles Davis; Wendy A Keitel
Higher antigen content improves the immune response to 2009 H1N1 influenza vaccine in HIV-infected adults: a randomized clinical trial.
The Journal of infectious diseases 2012;205(5):703-12.
2010: Peter G Stock; Burc Barin; Barbara Murphy; Douglas W Hanto; Jorge Diego; Jimmy Light; Charles Davis; Emily A Blumberg; David Simon; ARUNA SUBRAMANIAN; J Michael Millis; G Marshall Lyon; Kenneth Brayman; Doug Slakey; Ron Shapiro; J Keith Melancon; Jeffrey M Jacobson; Valentina Stosor; Jean L Olson; Donald M Stablein; Michelle E Roland
Outcomes of kidney transplantation in HIV-infected recipients.
The New England journal of medicine 2010;363(21):2004-14.
2010: Cristiana Cairo; Cheryl L Armstrong; Jean-Saville Cummings; Carl O Deetz; Ming Tan; Changwan Lu; Charles Davis; C. David Pauza
Impact of age, gender, and race on circulating γδ T cells.
Human immunology 2010;71(10):968-75.
2009: Anthony Amoroso; Bruce L Gilliam; Rohit Talwani; Colleen Boyce; Robert R Redfield; Charles Davis
Viral load decay in antiretroviral-naïve patients receiving once-daily tenofovir and emtricitabine plus twice-daily nevirapine.
HIV clinical trials 2009;10(5):320-3.
2008: Jean-Saville Cummings; Cristiana Cairo; Cheryl Armstrong; Charles Davis; C. David Pauza
Impacts of HIV infection on Vgamma2Vdelta2 T cell phenotype and function: a mechanism for reduced tumor immunity in AIDS.
Journal of leukocyte biology 2008;84(2):371-9.
2008: Jeremy S Bock; David J Riedel; Charles Davis
A prickly situation.
The American journal of medicine 2008;121(3):199-200.
2008: Michelle E Roland; B Barin; Laurie Carlson; Lynda Frassetto; Norah A Terrault; Ryutaro Hirose; Chris E Freise; Leslie Z Benet; Nancy L Ascher; John P Roberts; B Murphy; Marla Keller; Kim M Olthoff; Emily A Blumberg; K L Brayman; Stephen T Bartlett; Charles Davis; Joseph M McCune; Barry M Bredt; D M Stablein; Peter G Stock
HIV-infected liver and kidney transplant recipients: 1- and 3-year outcomes.
American journal of transplantation : official journal of the American Society of Transplantation and the American Society of Transplant Surgeons 2008;8(2):355-65.
2007: Bruce L Gilliam; Mohammad M Sajadi; Anthony Amoroso; Charles Davis; Farley R Cleghorn; Robert R Redfield
Tenofovir and abacavir combination therapy: lessons learned from an urban clinic population.
AIDS patient care and STDs 2007;21(4):240-6.
2005: Alonso Heredia; Charles Davis; Douty Bamba; Nhut Le; Muhammad Y Gwarzo; Mariola Sadowska; Robert C Gallo; Robert R Redfield
Indirubin-3'-monoxime, a derivative of a Chinese antileukemia medicine, inhibits P-TEFb function and HIV-1 replication.
AIDS (London, England) 2005;19(18):2087-95.
2005: Charles Davis; Stephanie B Troy
Brucellosis.
The New England journal of medicine 2005;353(10):1071-2; author reply 1071-2.
2005: Alonso Heredia; Charles Davis; Anthony Amoroso; Gregory H Taylor; Nhut Le; Douty Bamba; Robert R Redfield
In vitro suppression of latent HIV-1 activation by vitamin E: potential clinical implications.
AIDS (London, England) 2005;19(8):836-7.
2004: Lai-Xi Wang; Alonso Heredia; Haijing Song; Zhaojun Zhang; Biao Yu; Charles Davis; Robert R Redfield
Resveratrol glucuronides as the metabolites of resveratrol in humans: characterization, synthesis, and anti-HIV activity.
Journal of pharmaceutical sciences 2004;93(10):2448-57.
2004: Nicholas J Vietri; David P Dooley; Charles Davis; Jenice N Longfield; Patricia A Meier; Andrew C Whelen
The effect of moving to a new hospital facility on the prevalence of methicillin-resistant Staphylococcus aureus.
American journal of infection control 2004;32(5):262-7.
2004: Jose Bordon; Peter Evans; Nadia Propp; Charles Davis; Robert R Redfield; C. David Pauza
Association between longer duration of HIV-suppressive therapy and partial recovery of the V gamma 2 T cell receptor repertoire.
The Journal of infectious diseases 2004;189(8):1482-6.
2003: Alonso Heredia; Anthony Amoroso; Charles Davis; Nhut Le; Elise Reardon; Joyelle K Dominique; E Klingebiel; Robert C Gallo; Robert R Redfield
Rapamycin causes down-regulation of CCR5 and accumulation of anti-HIV beta-chemokines: an approach to suppress R5 strains of HIV-1.
Proceedings of the National Academy of Sciences of the United States of America 2003;100(18):10411-6.
2003: Richard Kowalski; Diane Post; Mary C Schneider; Judith Britz; Judy Thomas; Mark H Deierhoi; Andrew Lobashevsky; Robert R Redfield; Eugene J Schweitzer; Alonso Heredia; Elise Reardon; Charles Davis; Carol Bentlejewski; John Fung; Ron Shapiro; Adriana Zeevi
Immune cell function testing: an adjunct to therapeutic drug monitoring in transplant patient management.
Clinical transplantation 2003;17(2):77-88.
2003: Alonso Heredia; Charles Davis; Anthony Amoroso; Joyelle K Dominique; Nhut Le; Erin Klingebiel; Elise Reardon; Davide Zella; Robert R Redfield
Induction of G1 cycle arrest in T lymphocytes results in increased extracellular levels of beta-chemokines: a strategy to inhibit R5 HIV-1.
Proceedings of the National Academy of Sciences of the United States of America 2003;100(7):4179-84.
2001: Charles Davis; Alonso Heredia; Nhut Le; Joyelle K Dominique; Robert R Redfield
Differential human immunodeficiency virus-suppressive activity of reverse transcription inhibitors in resting and activated peripheral blood lymphocytes: implications for therapy.
Journal of human virology 2001;4(3):113-22.
2000: Alonso Heredia; Charles Davis; Robert R Redfield
Synergistic inhibition of HIV-1 in activated and resting peripheral blood mononuclear cells, monocyte-derived macrophages, and selected drug-resistant isolates with nucleoside analogues combined with a natural product, resveratrol.
Journal of acquired immune deficiency syndromes (1999) 2000;25(3):246-55.
2000: Deborah L Birx; Lawrence D Loomis-Price; Naomi E Aronson; J Brundage; Charles Davis; L Deyton; Robin P Garner; F Gordin; D Henry; W Holloway; T Kerkering; R Luskin-Hawk; John McNeil; N Michael; P Foster Pierce; D Poretz; Silvia Ratto-Kim; P Renzullo; N Ruiz; KV Sitz; G Smith; Carol O Tacket; M Thompson; E Tramont; B Yangco; R Yarrish; Robert R Redfield
Efficacy testing of recombinant human immunodeficiency virus (HIV) gp160 as a therapeutic vaccine in early-stage HIV-1-infected volunteers. rgp160 Phase II Vaccine Investigators.
The Journal of infectious diseases 2000;181(3):881-9.
1999: K J Lowry; K T Stephan; Charles Davis
Miliary tuberculosis presenting with rigors and developing unusual cutaneous manifestations.
Cutis; cutaneous medicine for the practitioner 1999;64(1):23-8.
1999: Josephine H Cox; Robin P Garner; Robert R Redfield; Naomi E Aronson; Charles Davis; N Ruiz; Deborah L Birx
Antibody-dependent cellular cytotoxicity in HIV type 1-infected patients receiving VaxSyn, a recombinant gp160 envelope vaccine.
AIDS research and human retroviruses 1999;15(9):847-54.
1999: Silvia Ratto-Kim; KV Sitz; Robin P Garner; Jerome H Kim; Charles Davis; Naomi E Aronson; N Ruiz; K Tencer; Robert R Redfield; Deborah L Birx
Repeated immunization with recombinant gp160 human immunodeficiency virus (HIV) envelope protein in early HIV-1 infection: evaluation of the T cell proliferative response.
The Journal of infectious diseases 1999;179(2):337-44.
1998: Dean L Mann; R P Garner; Debora Elizabeth Sites (Dayhoff); K Cao; M A Fernández-Viña; Charles Davis; Naomi E Aronson; N Ruiz; Deborah L Birx; Nelson L Michael
Major histocompatibility complex genotype is associated with disease progression and virus load levels in a cohort of human immunodeficiency virus type 1-infected Caucasians and African Americans.
The Journal of infectious diseases 1998;178(6):1799-802.
1998: Glenn Wortmann; Susan L Fraser; Naomi E Aronson; Charles Davis; R Scott Miller; J D Jackson; Charles N Oster
Failure of amphotericin B lipid complex in the treatment of cutaneous leishmaniasis.
Clinical infectious diseases : an official publication of the Infectious Diseases Society of America 1998;26(4):1006-7.
1992: Robert R Redfield; Deborah L Birx; N Ketter; V Polonis; S Johnson; Charles Davis; G Smith; C Oster; Donald S. Burke
Vaccine therapy using rgp 160 in early HIV infection.
AIDS research and human retroviruses 1992;8(8):1333.
1992: L I Gardner; John F Brundage; J G McNeil; M J Milazzo; Robert R Redfield; N E Aronson; D B Craig; Charles Davis; R H Gates; L I Levin
Predictors of HIV-1 disease progression in early- and late-stage patients: the U.S. Army Natural History Cohort. Military Medical Consortium for Applied Retrovirology.
Journal of acquired immune deficiency syndromes 1992;5(8):782-93.
1991: Robert R Redfield; Deborah L Birx; N Ketter; E Tramont; V Polonis; Charles Davis; J F Brundage; G Smith; S Johnson; A Fowler
A phase I evaluation of the safety and immunogenicity of vaccination with recombinant gp160 in patients with early human immunodeficiency virus infection. Military Medical Consortium for Applied Retroviral Research.
The New England journal of medicine 1991;324(24):1677-84.
1988: B A Gunn; Charles Davis
Staphylococcus haemolyticus urinary tract infection in a male patient.
Journal of clinical microbiology 1988;26(5):1055-7.
1987: Charles Davis; J L Carpenter; S Trevino; J Koch; A J Ognibene
In vitro susceptibility of Mycobacterium avium complex to antibacterial agents.
Diagnostic microbiology and infectious disease 1987;8(3):149-55.
1987: Kurt Kroenke; J F Hanley; JB Copley; J I Matthews; Charles Davis; C J Foulks; J L Carpenter
Improving house staff ordering of three common laboratory tests. Reductions in test ordering need not result in underutilization.
Medical care 1987;25(10):928-35.
1986: Kurt Kroenke; J F Hanley; JB Copley; J I Matthews; Charles Davis; C J Foulks; J L Carpenter
The admission urinalysis: impact on patient care.
Journal of general internal medicine 1986;1(4):238-42.